Not Tagged
grail
['pathfinder', 'detection']
very interesting data from the pathfinder study utilizing methylation-based screening for early cancer detection. 1.4% positive out of &gt;6000 individuals with less than a half of them actually having a cancer. predicted origin accurate. #esmo22 
VP Translational Medicine, Early Oncology, AstraZeneca. Previous Associate Director of Translational Science at MSKCC. Co-founder of https://t.co/sf253Xny69.